Long-term update of US GI Intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol 2012; 30: 4344–4351.
Authors: Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson III AB et al.
Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 Trial. Am J Clin Oncol 2012; 30: 1941–1948.
Authors: Peiffert D, Tournier-Rangeard L, Gerard JP, Lemanski C, Francois E, Giovannini M et al. et al.
Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomised RTOG trial 0315. J Natl Cancer Inst 2010; 102: 547–556.
Authors: Zachariah B, Gwede CK, James J, Ajani J, Chin LJ, Donath D et al.